Bioequivalence guideline for capecitabine makes public

The Korea Food and Drug Administration has published a new bioequivalence guideline for capecitabine tablets, defining that generic makers should conduct the above testing in patients with colorectal cancers breast cancer, for whom any medications are unnecessary.

The drug agency said this guideline will be of help for domestic firms to produce the generic version of capecitabine tablets in ...